Takeda Pharmaceutical Sold a subsidiary of the consumer business such as Alinamin August 16 at 16:41
Takeda Pharmaceutical Co., Ltd. announced that it will sell its subsidiary, Takeda Consumer Healthcare, which operates a business for general consumers known for its vitamin Alinamine, to the American investment fund Blackstone Group. did.
Takeda Pharmaceutical acquired Irish drug giant "Shire" last year for more than 6 trillion yen, and through the sale of this subsidiary, it aims to improve its financial position and develop highly profitable products such as the development of anti-cancer agents. Our policy is to concentrate management resources on businesses for medical institutions.